HBV—DNA检测在乙肝病毒携带者治疗和评估预后中的作用  

Action of HBV-DNA detection in treatment and assessment prognosis in hepatitis B virus carriers

作　　者：赵俊艳[1] 李红宇[1] 

机构地区：[1]济南市历下区人民医院,山东济南250014

出　　处：《医学检验与临床》2013年第1期29-30,共2页Medical Laboratory Science and Clinics

摘　　要：目的：探讨HBV-DNA检测在乙肝病毒携带者治疗和评估预后中的作用。方法：收集门诊及住院病人534例乙肝病毒携带者进行两对半及HBV—DNA检测，对结果进行分析。结果：HBeAg与HBV—DNA具有相关性（P〈0．01）。随访，随诊病例病毒量的高低与肝功能出现反复异常有关。结论：HBV—DNA定量检测是评价患者体内病毒复制更直接的指标及评估预后的重要依据。Objective ： To explore the detection of HBV-DNA in therapy and evaluate Hepatitis B virus carriers of prognosis. Meth0ds ： Five 534 hundred and thirty-four Hepatitis B virus carriers including out-patient and in-patient were-tested by HBV-M and HBV-DNA, then analyse the results. ResultS：There was correlation between HBeAg and HBV-DNA quantitative （ P〈0.01 ） . The interview of all these carriers shows that HBV quantitative related to repeatedly abnormal liver function. Conclusions ： HBV- DNA Quantitative detection is the direct index in evaluation of patients with viral replication and important basis in assessment of the prognosis.

关 键 词：HBV—DNA 乙型肝炎 乙肝病毒携带者 乙肝两对半 

分 类 号：R512.62[医药卫生—内科学]